Differential B- and T-cell activation in Wegener's granulomatosis

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 5 II, 1999, Pages 885-894

  Popa, Eliane R ^a,b   Stegeman, Coen A ^a   Bos, Nicolaas A ^b   Kallenberg, Cees G M ^a   Tervaert, Jan Willem Cohen ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Activation; B cells; Immunology; T cells; Wegener's granulomatosis

Indexed keywords

CD38 ANTIGEN; CD4 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MALE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; B-LYMPHOCYTES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; SOLUBILITY; T-LYMPHOCYTES; WEGENER GRANULOMATOSIS;

EID: 0033065098     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70434-3     Document Type: Article

References (36)

1. Kallenberg CGM, Cohen Tervaert JW, van der Woude FJ, Goldschmeding R, von dem Borne AEGKr, Weening JJ. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol Today 1991;12:61-4.
2. Savage CO, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997;349:553-8.
3. Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Int Med 1989;149:2461-5.
4. Nolle B, Specks U, Ludemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 1989;111:28-40.
5. Kallenberg CGM, Brouwer E, Mulder AHL, Stegeman CA, Weening JJ, Cohen Tervaert JW. ANCA-pathophysiology revisited. Clin Exp Immunol 1995;100:1-3.
6. Heeringa P, Brouwer E, Cohen Tervaert JW, Weening JJ, Kallenberg CG. Animal models of antineutrophil cytoplasmic antibody associated vasculitis. Kidney Int 1998;53:253-63.
7. Cohen Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, et al. Prevention of relapses of Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;336:709-11.
8. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993;36:365-71.
9. Cohen Tervaert JW. The value of serial ANCA testing during follow-up studies in patients with ANCA-associated vasculitis: a review. J Nephrol 1996;9:232-40.
10. Brouwer E, Cohen Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991;83:379-86.
11. + T-cell subsets in Wegener's granulomatosis. Rheumatol Int 1995;14:213-9.
12. Gephardt GN, Ahmad M, Tubbs RR. Pulmonary vasculitis (Wegener's granulomatosis): immunohistochemical study of T and B cell markers. Am J Med 1983;74:700-4.
13. Rasmussen N, Petersen J, Ralfkiaer E, Avnstrom S, Wiik A. Spontaneous and induced immunoglobulin synthesis and antineutrophil cytoplasm antibodies in Wegener's granulomatosis: relation to lymphocyte subpopulations in blood and active lesions. Rheumatol Int 1988;8:153-8.
14. Brouwer E, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Immunohistopathology of renal biopsies in Wegener's granulomatosis (WG): Clues to its pathogenesis? Kidney Int 1991;39:1055-6.
15. Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis: association with disease activity. Arthritis Rheum 1992;35:1088-96.
16. Stegeman CA, Cohen Tervaert JW, Huitema MG, Kallenberg CGM. Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol 1993;91:415-20.
17. Waldmann TA. The interleukin-2 receptor. J Biol Chem 1991;266:2681-4.
18. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
19. Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996;335:16-20.
20. Carrington CB, Liebow A. Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med 1966;41:497-527.
21. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994;87:671-8.
22. Spronk PE, van de Gun BTF, Limburg PC, Kallenberg CGM. B cell activation in clinically quiescent systemic lupus erythematosus is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T-cell activation. Clin Exp Immunol 1993;93:39-44.
23. Cohen Tervaert JW, Mulder L, Stegeman C, Elema J, Huitema M, The H, et al. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993;52:115-20.
24. Leid RW, Ballieux BE, van der Heijden I, Kleyburg-van der Keur C, Hagen EC, van Es LA, et al. Cleavage and inactivation of human C1 inhibitor by the human leukocyte proteinase, proteinase 3. Eur J Immunol 1993;23:2939-44.
25. Fink PC, Romer M, Haeckel R, Fateh-Moghadam A, Delanghe J, Gressner AM, et al. Measurement of proteins with the Behring nephelometer: a multicenter evaluation. J Clin Chem Clin Biochem 1989;27:261-76.
26. Babson AL. The IMMULITE Automated Immunoassay System. J Clin Immunoassay 1991;14:83-8.
27. Lund F, Solvason N, Grimaldi JC, Parkhouse RME, Howard M. Murine CD38: an immunoregulatory ectoenzyme. Immunol Today 1995;16:469-73.
28. Harada H, Kawano MM, Huang N, Harada Y, Iwato K, Tanabe O, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993;10:2658-63.
29. Mathieson PW, Lockwood CM, Oliveira DBG. T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Immunol Immunopathol 1992;63:135-41.
30. + lymphocyte subsets in Wegener's granulomatosis. Int Arch Allergy Immunol 1993;102:205-8.
31. Robb RJ, Munck A, Smith KA. T-cell growth factor receptors: quantitation, specificity and biological relevance. J Exp Med 1981;154:1455-74.
32. Cantrell DA, Smith KA. The interleukin-2 T-cell system: a new cell growth model. Science 1984;224:1312-6.
33. Smith KA. Interleukin-2: inception, impact and implications. Science 1988;240:1169-76.
34. Alcocer-Varela J, Alarcon-Riquelme M, Laffon A, Sanchez-Madrid F, Alarcon-Segovia D. Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus: correlation with proliferative responses and production of IL-2. J Autoimmun 1991;4:935-45.
35. Villarreal GM, Alcocer-Varela J, Llorente-L. Cytokine gene and CD25 antigen expression by peripheral blood T cells from patients with primary Sjögren's syndrome. Autoimmunity 1995;20:223-9.
36. Cohen Tervaert JW, Stegeman CA, Manson WL, Kallenberg CGM, Johnson WM. Staphylococcus aureus (SA) superantigens: a risk factor for disease reactivation in Wegener's granulomatosis (WG) [abstract]. J Am Soc Nephrol 1997;8:533A.